Read the Latest News

What Does Blood Pressure Have to Do with Chronic Pain?

To understand this possible connection, you have to consider how blood pressure is normally controlled by the nervous system.

Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment

Public Workshop Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment

National Academy of Medicine Study on Temporomandibular Disorders: From Research Discoveries to Clinical Treatment

An ad hoc committee, under the auspices of the National Academies of Sciences, Engineering, and Medicine's Health and Medicine Division, has been convened to study temporomandibular disorders (TMD) in a project entitled From Research Discoveries to Clinical Treatment.

Genetic Differences Contributing to TMD Susceptibility in Males

Temporomandibular disorders (TMD) are the leading cause of chronic orofacial pain. They represent a type of "idiopathic" pain disorder, meaning that the cause or causes are unknown, but research over the decade suggests a genetic component contributing to susceptibility.

National Academy of Medicine Study on Temporomandibular Disorders

The first meeting of the National Academy of Medicine Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment will be held Tuesday, January 29, 2019 at the National Academy of Sciences building in Washington, D.C.&

National Academy of Medicine Study on Temporomandibular Disorders

  • Jan 18, 2019

The first meeting of the National Academy of Medicine Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment will be held Tuesday, January 29, 2019 at the National Academy of Sciences building in Washington, D.C. 

An ad hoc committee will convene to address the current state of knowledge regarding TMD research, education and training, safety and efficacy of clinical treatments of TMD, and burden and costs associated with TMD. The committee will identify approaches to advance basic, translational, and clinical research in the field. The committee’s findings, conclusions, and recommendations will also inform development of policies related to evidence-based treatment and clinical management of TMD patients.

The afternoon session, scheduled from 1:30-5:00 p.m. Eastern Time, will offer the public an opportunity to understand the study's Statement of Task, and listen to presentations from key stakeholders.* The afternoon session will be available via webcast; however you will need to register. For those in the D.C. area, you are welcome to attend the meeting in person although registration is limited due to room capacity. The agenda and registration links can be found here.

*Please note there will be no public comment time at the January meeting, however, the committee will hold a patient/public stakeholder and public comment session at the committee’s March workshop (date TBD). 

TMJ Disorders

Comments:

Login or Register to add Comment